Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Federico Piñero, Melisa Dirchwolf, Mário G. Pessôa
Cells (2020) Vol. 9, Iss. 6, pp. 1370-1370
Open Access | Times Cited: 404

Showing 1-25 of 404 citing articles:

Advances and challenges in portable optical biosensors for onsite detection and point-of-care diagnostics
Sufian Rasheed, Tehreem Kanwal, Naseer Ahmad, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 173, pp. 117640-117640
Closed Access | Times Cited: 67
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 65
Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression
Shuai Wang, Lingyi Zhou, Ning Ji, et al.
Drug Resistance Updates (2023) Vol. 69, pp. 100976-100976
Closed Access | Times Cited: 52
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 29
Interaction of STIL with FOXM1 regulates SF3A3 transcription in the hepatocellular carcinoma development
Haijun Zhang, Lin Zhang, Zhichao Wu
Cell Division (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Highly Sensitive Digital and Analog Immunoassay Based on Submicron Magnetic Beads and Fluorescent Microspheres
Feng Gong, Xiaoyun Shan, Kebing Yi, et al.
Analytical Chemistry (2025)
Closed Access | Times Cited: 2
Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma
Shanshan Chen, Yongchao Zhang, Xiaoyan Ding, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 57
Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC
Yixiu Wang, Yongfa Zhang, Longrong Wang, et al.
Hepatology International (2022) Vol. 16, Iss. 6, pp. 1435-1447
Closed Access | Times Cited: 43
The SNHG1-Centered ceRNA Network Regulates Cell Cycle and Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma
Lin Zhou, Qing Zhang, Haibin Deng, et al.
The Tohoku Journal of Experimental Medicine (2022) Vol. 258, Iss. 4, pp. 265-276
Open Access | Times Cited: 42
The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
Xueying Zhao, Jin Chen, Shangqi Yin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 39
The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets
Ziwei Tang, Xue Li, Yanfeng Zheng, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 15
Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges
Shunzhen Zheng, Siew Wee Chan, Fei Liu, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1582-1582
Open Access | Times Cited: 12
Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers
Rumiana Tenchov, Aparna K. Sapra, Janet M. Sasso, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 586-613
Open Access | Times Cited: 11
A Facile Strategy for Multiplex Protein Detection by a Fluorescent Microsphere-Based Digital Immunoassay
Feng Gong, Zhiyou Tan, Xiaoyun Shan, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 8, pp. 3517-3524
Closed Access | Times Cited: 11
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 11
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, et al.
Cancer Letters (2024) Vol. 597, pp. 217061-217061
Closed Access | Times Cited: 10
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 10
Knockdown of liver cancer cell‐secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/STAT3 signaling
Shujie Xie, Xiang Li, Yan Jia, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 9
A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine
R.A. Youness, Hossam A. Hassan, Tasneem Abaza, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1245-1245
Open Access | Times Cited: 9
Biosensors for cancer detection: A review
Sourav Sarkar, Satakshi Hazra, Sanjukta Patra, et al.
TrAC Trends in Analytical Chemistry (2024), pp. 117978-117978
Closed Access | Times Cited: 9
ChatExosome: An Artificial Intelligence (AI) Agent Based on Deep Learning of Exosomes Spectroscopy for Hepatocellular Carcinoma (HCC) Diagnosis
Zhejun Yang, Tongtong Tian, Jilie Kong, et al.
Analytical Chemistry (2025)
Closed Access | Times Cited: 1
The advanced development of molecular targeted therapy for hepatocellular carcinoma
Tao Yan, Lingxiang Yu, Ning Zhang, et al.
Cancer Biology and Medicine (2022) Vol. 19, Iss. 6, pp. 1-16
Open Access | Times Cited: 38
Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma
Mengjiao Xu, Yang Liu, Yanjie Lin, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 34
Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation
Xiaoli Liao, Junming Chen, DongCheng Luo, et al.
Pathology & Oncology Research (2023) Vol. 28
Open Access | Times Cited: 20
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top